Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
fecal microbiota transplant (Judith Kelsen)
- Development stage
- Unknown
- Lead developer
- Judith Kelsen
- Modality
- Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Rectal
01
Overview
Fecal microbiota transplant (FMT) is an investigational biological treatment being studied for pediatric patients (ages 3-21) with recurrent or moderate to severe Clostridioides difficile infection, both with and without inflammatory bowel disease. This therapeutic approach involves transplanting the complete fecal microbiota from healthy, screened donors into the patient's gastrointestinal tract. The primary mechanism of action is the restoration of a healthy and diverse gut microbiome, which enhances colonization resistance against pathogenic bacteria like C. difficile. A Phase 1 clinical trial (NCT02636517) led by Dr. Judith Kelsen at the Children's Hospital of Philadelphia is evaluating the safety and efficacy of this modality, and characterizing the changes in the gut microbiome before and after transplantation.
- Other names
- FMTfecal transplantfecal bacteriotherapystool transplantintestinal microbiota transplant
Beyond the preview
Go deeper on fecal microbiota transplant (Judith Kelsen).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on fecal microbiota transplant (Judith Kelsen).